AstraZeneca Reports Positive Phase 2 Results For Cancer Drug
February 17, 2017 at 12:32 PM EST
The company stock has gained over 5 percent this year so far. Its 12 months performance is a little shaky as the stock lost 3 percent of its value during this time period.
